I "get" the "club" concept that benefits as long as this thing keeps going, they keep getting paid. But where is the money coming from, continual small placements? How long does that keep going, for the club to keep getting paid handsomely, while we mushrooms sit on hopes for the science winning in the end despite management?! The bridge is out somewhere aheed if something doesn't give with study results.

All of the big players in the 70% would ALL benefit greatly by getting these studies done. I also get just tleeting this roll one and getting paid, and avoiding the fear of failure on studies, that might end the joy ride. But the joy ride will be coming to an end without good study results with Covd and BoM2, either/or/and. So with that in mind, why aren't the big players stepping up to push Covid along, and also finance BoM2 (to augment along with Hepa's 50% commitment)?

Players like Hepa, Eastern, Ori, Don, etc, own so much stock that the will likely become wealthy beyond belief with good results with either of those studies, and certainly if both pull into the staion on time and with good results. Whatever getting paid along the line is worth, getting the show on the road is worth a logarythmically higher value, and most likely any of the big player could either right a check or find a way (personal loan?) to finance the balance of BoM2.

BoM2 with the BTD is set up to win this time, based on so many past reults and numbers from previous studies, and new design. This study should be busting down the door to get started and not waiting for Covid, although I understand the benefit of Covid success driving and financing BoM2. I just can't understand why we aren't already moving forward with BoM2 in China where Hepa and Ori have influence and deep pockets, to get the timeline to good results moving.

There is just so much at stake financially for some of these big players, with BoD insights, and influence and access to a big mega-market.

It's just baffling, honestly.

Well, back to "hoping" (and "hope" is not a strategy) for news of good Covid results soon, for now ...